Abstract Guidelines

Important Dates for Abstract Submissions

  • Last date for abstract submission: March 02, 2025
  • Notification of acceptance for oral/ poster presentations: March 9, 2025

It is mandatory for the presenting authors to register for the conference

The abstracts must be submitted in one of the following categories:

  1. Conditioning Regimen
  2. Supportive care
  3. Infections in HSCT
  4. Late effects
  5. Graft versus Host Disease
  6. Paediatric HSCT
  7. Basic science research in HSCT
  8. Nursing
  9. Quality management
  10. Data Management
  11. Transplant in hematological malignancies
  12. Transplantation in benign diseases
  13. Alternate Donor Transplantation
  14. Post transplant complications excluding GVHD
  15. Cellular Therapy.

Guidelines for Submission of Abstracts

  • Maximum 500 words, which would not include the title of the abstract and author affiliations.
  • All abstracts are subject to review by the Scientific Programme Committee and acceptance into the program is not guaranteed.
  • Abstracts should be prepared and submitted on the abstract portal of ISBMT 2025
  • All abstracts must be accompanied by the Declaration Form from the presenting author
  • Submission of the abstract carries with it an obligation to present the accepted abstract without any change in scientific content during the allotted time at ISBMT 2025.
  • Withdrawal of presentation should be intimated to the conference secretariat on or before March 19, 2025.
  • If the application is not sent in the prescribed format, it will not be considered for review.
  • Preference for oral or poster presentation may be indicated at the time of submission of abstract though the final decision of the scientific programme committee will be binding.
  • Top 3 Oral and 3 posters respectively will receive the awards, details of which will be announced at the end of the meeting

 

Abstract Format

The abstract may include one table or graph.

Please use ‘Calibri' font. The font size should be 11 points or bigger.

Abstract Title

Please write the title in Sentence Case. Do not use quotation marks.

(Example: The results of the research case study and its participants)

Leave one blank line between the title and authors/ affiliations.

Authors

The full names (no initials) of all participating authors must be included on the abstract. Please do not include degrees or professional titles.

The name of the presenting author should be underlined.

Author Affiliations

Please include the name of your organization, city, the state, and the country. Use a superscript number to link each author with their affiliation.

Abstract Text

Abstracts that merely state the results which will be presented will be subject to rejection.

The Committee suggests that the abstract follow the format outlined below.

  • Aim
  • Methods
  • Results
  • Conclusions

 

DECLARATION FORM

Conflict of Interest Statement

If the research described in the abstract was supported by a commercial company, you must indicate the company's role in analysing the data or preparing the abstract.

"No conflict of interest to disclose"                         

"This research was supported by __________. The company had no role in analysing the data or preparing the abstract."

"This research was supported by __________. The company inserts free text describing company role in data analysis or abstract preparation."

Declaration form submitted by ……………………………………………………..Date……………